-
- (-%)
Related Stories
- Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
- Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022
- MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance ...
- Cardiff Oncology Formally Introduces Scientific Advisory Board
- Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board